VIP and nongerminomatous germ cell tumor: In early series, cisplatin was combined with vinblastine (or etoposide) and ifosfamide (VeIP, VIP; Pizzocaro et al, 1992; Farhat et al, 1996; McCaffrey et al, 1997; Miller et al, 1997; Loehrer et al, 1998), and numerous series have reported cure rates of 15–42% with these combinations used alone or with surgery in patients with NSGCT (Pizzocaro et al, 1992; McCaffrey et al, 1997; Loehrer et al, 1998).